Sylogent Releases SYQUENCE 2.0 Data and Information Platform to Pharmaceutical Industry

Press Release ( - BRISTOL, Pa. - Mar 15, 2018 - Sylogent today released SYQUENCE 2.0, a data and information management platform designed specifically for the pharmaceutical industry. The new release includes planning and tracking functionality, along with improved smart form templates that eliminate the need for desktop-based Excel spreadsheets. SYQUENCE can be implemented as a standalone application or as middle-ware platform to interact with existing data and information management applications. 

“The pharmaceutic industry has unique data and process challenges that require functionality not found in existing off-the-shelf-software,” stated Sylogent CEO Jack Yeager, who has been developing process automation software for over 25 years.

“New transparency and data disclosure regulations impact the entire organization, and they must leverage information automation to ensure regulation compliance, public data consistency and resource efficiency,” added Yeager. “They just don’t have the time, money or people to use existing methods.”

The pharmaceutic industry has unique data and process challenges that require functionality not found in existing off-the-shelf-software.

Jack Yeager


Beyond using SYQUENCE to support its existing publication planning and data disclosure offerings, Sylogent will now offer structured Submissions and eTMF planning & tracking.

For additional information visit or email

Sylogent delivers software and business services to the pharmaceutical industry, focused specifically on the information required to bring a product to market.   The company is uniquely positioned to operate within core business units, and across the enterprise, to ensure timely completion of critical information, maximize compliance goals and reduce risk management liability.  

Media Contact
Jack Yeager

Source : Sylogent
Business Info :

You may also like this  

DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login